Trial Profile
A Multi-centre, Double-blind, Randomised, Parallel-group, Placebo-controlled, Phase III Confirmatory Study to Assess Efficacy and Safety of the Moderate Sedation of ICI35,868 With and Without EES0000645/A on Gastrointestinal Endoscopy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Propofol (Primary) ; Soya oil emulsion
- Indications Sedation
- Focus Registrational; Therapeutic Use
- Acronyms Kagami_SDS
- Sponsors AstraZeneca
- 19 May 2015 New trial record